Key clinical points. Pulmonary embolism. •. Pulmonary embolism is a common diagnosis and may be associated with recurrent venous thromboembolism, bleeding due to anticoagulant therapy. Pulmonary embolism PE is a common and potentially fatal form of venous thromboembolic disease. It is the third most common cause of cardiovascular disease. Pulmonary embolism PE occurs when there is an interruption of blood flow in the pulmonary artery or its branches due to a pulmonary embolism. Pulmonary embolism is a common and potentially fatal cardiovascular disease that must be promptly diagnosed and diagnosed. treaty; Abstract. Pulmonary embolism PE is an important public health problem. In,the European Society of Cardiology in collaboration with the European,Abstract. Prompt evaluation and therapeutic intervention in cases of suspected PE pulmonary embolism are of fundamental importance for improving outcomes; Metric. Abstract. PE pulmonary embolism is caused by emboli, which originated from venous thrombi, traveling to and, Review article. Medical progress. Acute pulmonary embolism. Author: Victor F. Tapson, MD Author information and affiliations. Published. N Engl J, 358: 1037 - 1052. DOI: Michael B hm, Wissam Jaber and Felix Mahfoud. Nature Reviews 670-684, 2023 Cite this article. 15 thousand hits. 81, Pathophysiology of acute pulmonary embolism. The vast majority of cases of acute PE arise from thrombus in the leg or pelvic veins, although emboli can originate from other sources such as the subclavian axillary system or the renal system. These thrombi travel and embolize in the pulmonary arteries, causing blockage of the pulmonary arteries. Acute pulmonary embolism may present with non-specific signs and symptoms and therefore diagnosis and management may not be so simple. This review outlines new guidelines for managing PE in the Indian context. The exact prevalence in the Indian population is not well defined, although recent studies suggest that pulmonary embolism (PE) is the third most common cause of cardiovascular death in the United States. Appropriate risk stratification is an important component of the initial evaluation for the acute management of these patients. Echocardiography plays a crucial role in risk stratification of patients with PE. In this context, high-risk pulmonary embolism PE, which presents as shock or persistent hypotension, is a life-threatening disease associated with high mortality and morbidity at 1,2,3 · daily mortality rate of patients with PE who develop levels of shock, and that of patients with intervals of cardiac arrest. 4, 5. Higher number of deaths in, Cardiovascular diseases are the leading cause of death among women. Pulmonary embolism (PE) is the third most common cause of cardiovascular death, after myocardial infarction and stroke. Our objective was to evaluate the characteristics and outcomes of PE specifically in women and explore sex-based differences. We conducted a systematic analysis, 1. Introduction. PI pulmonary infarction results from blockage of the distal pulmonary arteries, causing an ischemic insult that further leads to necrosis of the obstructed lung tissue. PI commonly occurs due to complications of another existing disease, such as pulmonary embolism (PE) in most cases, but, Purpose of Review The purpose of this review article is to analyze the current information on diagnosis, prognosis, treatment and interventional therapies regarding the treatment of PE pulmonary embolism. As well as reviewing the results achieved by pulmonary embolism response teams.